Fri.Jun 23, 2023

article thumbnail

Senate Introduces Bill to Combat High Pharmacy DIR Fees

Drug Topics

The Protect Patient Access to Pharmacies Act will help to secure Medicare patients’ freedom to receive medications and care from the pharmacy of their choice.

187
187
article thumbnail

STAT+: Two type 1 diabetes patients now freed from insulin shots with cell therapy, Vertex reports

STAT

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.  The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AWS launches generative AI center backed by $100M investment

Fierce Healthcare

Amazon Web Services launched a new innovation center focused on generative AI backed by a $100 million investment, its most recent bid to keep up with the AI race. | Amazon's cloud unit launched the AWS Generative AI Innovation Center with a $100 million investment, its most recent bid to keep up with the AI race.

126
126
article thumbnail

Opinion: Peter Hotez is not alone: Online harassment of doctors is a public health issue

STAT

Father’s Day weekend was anything but calm on Twitter, which erupted as vaccine expert Peter Hotez was challenged online to a debate by podcaster and former reality TV host Joe Rogan. Rogan’s challenge began when Hotez, a professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine and vaccine expert, tweeted his  concern about Rogan’s three-hour interview with longtime anti-vaccine activist  and presidential candidate Robert F.

Vaccines 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

First Gene Therapy to Treat Pediatric Duchenne Muscular Dystrophy Approved by FDA

Drug Topics

The accelerated approval of delandistrogene moxeparvovec-rokl is “based on expression of Elevidys micro-dystrophin observed in patients treated with ELEVIDYS,” according to Sarepta Therapeutics.

FDA 98
article thumbnail

Innovation is Necessary to Preserve Independent, Community Pharmacy

Pharmacy Times

Pharmacists can recognize evidence of successful interventions and learn how to integrate them into their own practice.

More Trending

article thumbnail

Defining Indolent Relapse Multiple Myeloma

Pharmacy Times

Dr Haumschild opens the discussion with Larry Anderson, MD, PhD, and Gabe Hinojosa, PharmD, BCOP, regarding various states of relapse in multiple myeloma.

123
123
article thumbnail

How a six-in-one vaccine could soon help the world get rid of polio for good

STAT

Polio eradication is a delicate dance. And one of the biggest challenges facing the people trying to choreograph its final steps is how to phase out use of oral polio vaccines. The oral vaccines have brought the paralyzing viruses to the brink of  annihilation; so far this year there have only been six cases detected, five in Afghanistan and one in Pakistan.

Vaccines 113
article thumbnail

Pharmacy Technicians Are Vital to Long-term Vaccination Expansion

Pharmacy Times

As the COVID-19 Public Health Emergency and PREP Act Expansions end, the ability of technicians to immunize patients in the future remains unclear.

Vaccines 123
article thumbnail

‘We fail people’: New data on disparities in Medicaid access to opioid addiction treatment

STAT

An estimated 82,998 people died from opioid overdoses in the U.S. last year. A new study published Friday in JAMA Health Forum drives home how lack of access to lifesaving medications could contribute to these preventable deaths. The study is the most comprehensive Medicaid analysis of opioid addiction to date, analyzing a national claims dataset with 76 million patient data points between 2016 and 2018.

Insurance 107
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pharmacy Technicians With Community Health Worker Training Can Improve the Value of The Pharmacy in Health Care

Pharmacy Times

Community health workers can address issues of health equity to enhance the services of the pharmacy and support a value-based care model.

123
123
article thumbnail

Industry Voices—Hospitals can't lose sight of infection control as COVID recedes

Fierce Healthcare

The need for capable healthcare staff was an urgent concern for me as my surgery for a major medical condition was placed on hold. | Unless we commit to a reliable and robust measurement system of hospital-acquired infections, we will continue to have a stressed workforce and need to rely on data generated in other countries.

Hospitals 105
article thumbnail

STAT+: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial

STAT

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy. The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full   results,  published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the Americ

104
104
article thumbnail

Psylo signs research deal with Daiichi Sankyo for psychiatric therapies

Pharmaceutical Technology

Psylo and Daiichi Sankyo have signed a sponsored research deal to advance the development of non-hallucinogenic psychiatric therapies.

119
119
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Using its Covid know-how, Color Health aims to make cancer screenings convenient

STAT

Color Health wants to take away any reason you might have for skipping screenings for cancer.  The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get

Insurance 102
article thumbnail

Moderna Files for FDA Authorization of Updated COVID-19 Vaccine

Drug Topics

Pending authorization of the XBB.1.5 vaccine, the company said that doses would be available in time for fall vaccination.

article thumbnail

Opinion: The staggering financial burden of giving birth — even with insurance

STAT

The burden of high health care costs and medical debt in the U.S. is no secret. Medical debt affects one in five adults in the U.S., with an average burden of more than $20,000 for each medical debtor. As primary care physicians, we frequently witness the effects of these financial burdens, particularly for our older or sicker patients with expensive medical conditions.

Insurance 100
article thumbnail

What to avoid when taking gabapentin

The Checkup by Singlecare

It’s likely you’ve heard of gabapentin: In 2022, the Centers for Disease Control and Prevention (CDC) reported that it was the 7th most commonly prescribed medication in the U.S. Gabapentin is approved by the U.S. Food and Drug Administration (FDA) to treat postherpetic neuralgia from shingles , partial seizures due to epilepsy , and moderate to severe restless legs syndrome (RLS).

article thumbnail

In absence of Roe v. Wade, an abortion doctor dwells on all the patients she does not see

STAT

Last year, just a few months after the Supreme Court’s reversal of Roe v. Wade ended the constitutional right to abortion in the United States, Christine Henneberg published a memoir on two simultaneous life-defining experiences: carrying her first pregnancy during her first year performing abortions. This was long after another transformative journey: traveling and living in a rural Indian village at the foothills of the Himalayas when Henneberg first wanted to be a writer.

99
article thumbnail

Jazz brings the noise to the FDA with lawsuit over approval of Avadel's narcolepsy drug Lumryx

Fierce Pharma

After years of using the patent system to delay competition from a rival company and then exhausting that ploy early this year, Jazz Pharmaceuticals is taking a new route—suing the FDA. | After years of using the patent system to delay competition to its key Xyrem/Xywav franchise from a rival company, Jazz Pharmaceuticals is taking a new route—suing the FDA.

FDA 98
article thumbnail

Drinking wine associated with reduced risk of adverse cardiovascular outcomes

Hospital Pharmacy Europe

Wine drinking is linked to a lower risk of death from cardiovascular disease (CVD) but also reduces the risk of developing both CVD and coronary heart disease (CHD), according to the findings of a recent meta-analysis. Previous studies have hinted that the polyphenolic content of wine confers a cardio-protective effect whereas consumption of spirits , increases the risk of ventricular arrhythmias.

article thumbnail

First RNA CAR-T therapy autoimmunity trial shows potential

European Pharmaceutical Review

Study data from a major trial has demonstrated RNA CAR-T (rCAR-T) therapy Descartes-08 facilitated significant and long-lasting clinical improvement in generalised myasthenia gravis (gMG). This is the first clinical trial using rCAR-T to treat autoimmunity. It is also the first successful Phase II trial using an engineered cell therapy for autoimmunity.

article thumbnail

JCVI backs RSV routine vaccination for babies and older adults in the UK

Hospital Pharmacy Europe

The UK should introduce routine vaccination for respiratory syncytial virus (RSV) to protect babies and older adults, the Joint Committee on Vaccination and Immunisation (JCVI) has recommended. It has made the early recommendations after reviewing several vaccines currently in development to allow sufficient lead time for the Government to get a policy and programme in place, a statement said.

article thumbnail

GSK escapes first state-level Zantac jury trial with settlement

Fierce Pharma

A month before it was set to take the stand in the highly anticipated first Zantac-related trial, GSK scratched the case with a settlement. | GSK can now wipe an upcoming California Zantac trial off its plate with a confidential settlement a month before what would have been the first state-level trial.

98
article thumbnail

Biden directs HHS to boost contraception access, a year after Dobbs decision

STAT

WASHINGTON – President Biden on Friday told federal health officials to boost contraception access, the administration’s latest attempt to shore up reproductive rights as abortion limits snowball across the country. The president’s executive order, released this morning, instructs the Health and Human Services Department to ensure people on commercial insurance are getting contraception at no cost — a requirement under the Affordable Care Act — and consider mov

article thumbnail

Study: 10% of NHS Health Care Workers Experienced Suicidal Thoughts During COVID-19 Pandemic

Pharmacy Times

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

122
122
article thumbnail

Walgreens hosts LinkedIn Live discussion on the importance of diversity in clinical trials

Drug Store News

Walgreens brought together internal and industry leaders for a LinkedIn Live discussion on the importance of diversity in clinical trials and ongoing efforts to reduce barriers to participation, especially in underserved communities.

97
article thumbnail

STAT+: At a defunct power station, the U.K. and Moderna celebrate a partnership meant to be an engine for science

STAT

LONDON — Back in the 1950s, Battersea Power Station, a towering brick structure on the south bank of the Thames, supplied a fifth of London’s electricity, an economic engine that even powered Buckingham Palace. The coal-fired plant was decommissioned decades ago. But on Thursday evening, in an art deco, gold-and-glass control room in the recently retrofitted power station — now a multi-use development complete with apartments and a cinema — the U.K. government and the

96
article thumbnail

CandyRific releases Disney100 limited-edition dispensers, candy cases

Drug Store News

The Disney100 Collectible candy dispensers and Disney Mickey Mouse and Minnie Mouse gift set will be ready for shipping in late summer/early fall.

105
105
article thumbnail

Insider’s Guide to Manufacturing, QC, and Operational Excellence

ISPE

Insider’s Guide to Manufacturing, QC, and Operational Excellence Trudy Patterson Fri, 06/23/2023 - 10:23 iSpeak Blog iSpeak Insider’s Guide to Manufacturing, QC, and Operational Excellence Dante Amatangelo Amanat Kaur Niranjan S. Kulkarni, PhD 23 June 2023 The 2023 ISPE Annual Meeting & Expo features Manufacturing, Quality Control, and Operational Excellence as one of the key content areas.

article thumbnail

Vortioxetine use for depression in early-stage dementia shows significant benefits

Hospital Pharmacy Europe

Vortioxetine improves depressive symptoms, cognitive performance, functioning and health-related quality of life in patients with both major depressive disorder and early-stage dementia, according to a recent trial. In a significant proportion of patients, depressive symptoms and dementia are related. However, there is insufficient evidence to support the use of antidepressants to treat depression in patients with dementia.

Dosage 94
article thumbnail

Differentiating Treatment Strategies for Indolent Versus Aggressive Relapse MM

Pharmacy Times

Medical experts discuss treatment options for indolent and aggressive relapse multiple myeloma.

123
123
article thumbnail

STAT+: EU poised to reject Amylyx’s ALS drug, as the company vows an appeal

STAT

LONDON — European regulators are on the verge of rejecting an ALS drug from Amylyx Pharmaceuticals, all but dooming the medicine’s chances of entering the E.U. market for now. The negative recommendation issued Friday by a European Medicines Agency committee is not a surprise. Last month, Amylyx said that the agency was headed toward a negative review.

93
article thumbnail

Clover Health settles lawsuits alleging that it hid a federal probe from investors

Fierce Healthcare

Clover Health has reached a settlement in lawsuits alleging that the Medicare Advantage insurtech had not been forthright with investors when the company went public, the company announced in a

97